| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
180,310,000 |
| Market
Cap: |
41.24(B) |
| Last
Volume: |
799,597 |
Avg
Vol: |
864,930 |
| 52
Week Range: |
$191.51 - $228.9 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Seagen is a biotechnology company that develops and commercializes targeted therapies to treat cancer. Co. is commercializing ADCETRIS®, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas, PADCEV®, or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers, TIVDAK™, or tisotumab vedotin-tftv, for the treatment of certain metastatic cervical cancers, and TUKYSA®, or tucatinib, for treatment of certain metastatic HER2-positive breast cancers. Co. is also developing a pipeline of therapies for solid tumors and blood-related cancers designed to address unmet medical needs and improve treatment outcomes for patients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
39,326 |
449,967 |
| Total Sell Value |
$0 |
$0 |
$8,245,949 |
$81,866,696 |
| Total People Sold |
0 |
0 |
7 |
8 |
| Total Sell Transactions |
0 |
0 |
18 |
69 |
| End Date |
2024-03-31 |
2023-12-29 |
2023-06-30 |
2022-06-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Jp Morgan Partners Bhca Lp |
10% Owner |
– – • |
2007-12-10 |
4 |
S |
$12.63 |
$268,059 |
I/I |
(21,224) |
28,088 |
|
- |
|
| Akkaraju Srinivas |
Director |
– • – |
2007-12-10 |
4 |
S |
$12.63 |
$264,725 |
I/I |
(20,960) |
1,043,112 |
|
- |
|
| Simpson Todd E |
Chief Financial Officer |
• – – |
2007-09-26 |
4 |
S |
$11.90 |
$383,952 |
D/D |
(32,250) |
0 |
|
- |
|
| Simpson Todd E |
Chief Financial Officer |
• – – |
2007-09-26 |
4 |
OE |
$4.45 |
$153,638 |
D/D |
32,250 |
18,750 |
|
- |
|
| Rosenberg Morris |
Sr. VP, Development |
• – – |
2007-09-26 |
4 |
S |
$11.90 |
$178,995 |
D/D |
(15,000) |
0 |
|
- |
|
| Rosenberg Morris |
Sr. VP, Development |
• – – |
2007-09-26 |
4 |
OE |
$6.72 |
$100,800 |
D/D |
15,000 |
2,500 |
|
- |
|
| Dobmeier Eric |
Chief Business Officer |
• – – |
2007-09-25 |
4 |
OE |
$2.77 |
$84,813 |
D/D |
20,629 |
24,427 |
|
- |
|
| Dobmeier Eric |
Chief Business Officer |
• – – |
2007-09-20 |
4 |
S |
$11.87 |
$22,604 |
D/D |
(1,900) |
3,798 |
|
- |
|
| Dobmeier Eric |
Chief Business Officer |
• – – |
2007-09-20 |
4 |
OE |
$5.25 |
$9,975 |
D/D |
1,900 |
4,198 |
|
- |
|
| Dobmeier Eric |
Chief Business Officer |
• – – |
2007-09-20 |
4 |
S |
$11.72 |
$225,367 |
D/D |
(19,100) |
3,798 |
|
- |
|
| Dobmeier Eric |
Chief Business Officer |
• – – |
2007-09-20 |
4 |
OE |
$5.25 |
$100,275 |
D/D |
19,100 |
4,098 |
|
- |
|
| Dobmeier Eric |
Chief Business Officer |
• – – |
2007-09-20 |
4 |
S |
$11.50 |
$81,727 |
D/D |
(7,100) |
3,798 |
|
- |
|
| Dobmeier Eric |
Chief Business Officer |
• – – |
2007-09-20 |
4 |
OE |
$5.25 |
$37,275 |
D/D |
7,100 |
4,398 |
|
- |
|
| Dobmeier Eric |
Chief Business Officer |
• – – |
2007-09-20 |
4 |
S |
$11.57 |
$192,261 |
D/D |
(16,500) |
3,798 |
|
- |
|
| Dobmeier Eric |
Chief Business Officer |
• – – |
2007-09-20 |
4 |
OE |
$5.25 |
$86,625 |
D/D |
16,500 |
5,598 |
|
- |
|
| Dobmeier Eric |
Chief Business Officer |
• – – |
2007-09-19 |
4 |
S |
$11.60 |
$128,384 |
D/D |
(11,000) |
3,798 |
|
- |
|
| Dobmeier Eric |
Chief Business Officer |
• – – |
2007-09-19 |
4 |
OE |
$5.25 |
$57,750 |
D/D |
11,000 |
5,098 |
|
- |
|
| Dobmeier Eric |
Chief Business Officer |
• – – |
2007-09-19 |
4 |
S |
$11.50 |
$512,167 |
D/D |
(44,400) |
3,798 |
|
- |
|
| Dobmeier Eric |
Chief Business Officer |
• – – |
2007-09-19 |
4 |
OE |
$4.45 |
$213,389 |
D/D |
44,400 |
5,198 |
|
- |
|
| Lippman Marc E |
Director |
– • – |
2007-09-17 |
4 |
B |
$10.62 |
$21,240 |
I/I |
2,000 |
10,000 |
2.1 |
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2007-08-22 |
4 |
S |
$10.94 |
$820,860 |
D/D |
(74,000) |
1,053,168 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2007-08-21 |
4 |
S |
$10.90 |
$722,047 |
D/D |
(65,700) |
1,127,168 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2007-08-21 |
4 |
OE |
$3.00 |
$341,100 |
D/D |
113,700 |
1,129,168 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2007-08-21 |
4 |
S |
$10.97 |
$80,497 |
D/D |
(7,332) |
1,079,168 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2007-08-20 |
4 |
S |
$11.10 |
$794,612 |
D/D |
(71,300) |
1,086,500 |
|
- |
|
1805 Records found
|
|
Page 59 of 73 |
|
|
